Byoung Yong Shim

2 articles listing Byoung Yong Shim in Nature Communications, indexed by Paperzzz from Crossref and OSF.

1. Author Correction: DKN-01 and tislelizumab as second-line therapy in DKK1-high gastroesophageal adenocarcinoma: DisTinGuish trial part B Nature Communications
2. DKN-01 and tislelizumab as second-line therapy in DKK1-high gastroesophageal adenocarcinoma: DisTinGuish trial part B Nature Communications